The WHO Global Traditional Medicine Centre is launching a series of working papers designed to document and examine traditional, complementary and integrative medicine (TCIM) worldwide. The inaugural ...
CSO raises concern over inclusion of Dr Naresh Trehan in Committee to review pharma marketing practices: Our Bureau, New Delhi Monday, October 26, 2026, 14:15 Hrs [IST] Raising co ...
African Medicines Agency and EMA issue joint guidance on Ebola vaccine development: Amsterdam, The Netherlands Monday, October 26, 2026, 14:00 Hrs [IST] EMA’s Emergency Task For ...
Roche presents positive results from phase III IMAgINATION study of sefaxersen to treat primary IgA nephropathy at ASN Kidney Week 2026: Basel Monday, October 26, 2026, 13:00 Hrs ...
Sun Pharma presents long-term follow-up data on Unloxcyt at ESMO 2026: Our Bureau, Mumbai Monday, October 26, 2026, 12:45 Hrs [IST] Sun Pharmaceutical Industries Limited announced ...
India's diversity in genetics is a scientific advantage in clinical research: Dr Seema Pai: Nandita Vijayasimha, Bengaluru Monday, October 26, 2026, 08:00 Hrs [IST] India’s dive ...
Manufacturers & marketing cos face logistical bottleneck following NPPA’s order on TMR of cancer drugs: Peethaambaran Kunnathoor, Chennai Monday, October 26, 2026, 08:00 Hrs [IS ...
CDSCO acts on registration of one more Ethics Committee for violation of NDCT Rules: Gireesh Babu, New Delhi Monday, October 26, 2026, 08:00 Hrs [IST] The Central Drugs Standard C ...
Maharashtra leads bulk drug PLI scheme with 19,180 MT capacity across five projects: Shardul Nautiyal, Mumbai Monday, October 26, 2026, 08:00 Hrs [IST] Maharashtra has recorded an ...
The Jan Aushadhi Kendras (JAKs) under the flagship scheme of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) run by the Department of Pharmaceuticals (DoP), has reported a growth of 8% in sales ...
Mundipharma presents additional results from global phase III ReSPECT trial of Rezzayo for prophylaxis of IFDs in adult patients undergoing allo-HSC at IDWeek 2026: Cambridge, UK ...
Mankind Pharma, India’s fourth largest pharmaceutical Company announced its financial results for the second quarter and half year ended 30th September 2026. The company's revenue from operations ...